Moody Aldrich Partners’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.01M Sell
312,858
-21,515
-6% -$507K 1.44% 10
2026
Q1
$5M Buy
334,373
+192,309
+135% +$3.28M 0.9% 45
2025
Q4
$2.07M Sell
142,064
-257,642
-64% -$4.49M 0.39% 110
2025
Q3
$7.17M Sell
399,706
-36,651
-8% -$538K 1.36% 10
2025
Q2
$7.45M Buy
436,357
+70,895
+19% +$709K 1.44% 12
2025
Q1
$2.65M Buy
365,462
+20,073
+6% +$228K 0.55% 71
2024
Q4
$4.85M Buy
+345,389
New +$5.1M 0.9% 40

Other funds holding CORZ

Moody Aldrich Partners's CORZ Position: Q2 2026 in Review

Moody Aldrich Partners reduced its Core Scientific (CORZ) stake by 6.4% in Q2 2026, selling an estimated $507K and leaving 312,858 shares worth $8.01M. The position accounts for 1.44% of the portfolio, ranked #10.

Moody Aldrich Partners first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. 66 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Moody Aldrich Partners held 312,858 shares of Core Scientific worth $8.01M as of Q2 2026.
  • Moody Aldrich Partners sold 21,515 Core Scientific shares in Q2 2026, an estimated $507K.
  • Core Scientific made up 1.44% of Moody Aldrich Partners's portfolio in Q2 2026, its #10 holding.
  • Moody Aldrich Partners first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • 66 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.